首页 > 最新文献

JAMA ophthalmology最新文献

英文 中文
Pedunculated Palpebral Conjunctival Papilloma 带蒂眼睑结膜乳头状瘤
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-15 DOI: 10.1001/jamaophthalmol.2025.5767
Wisam O. Najdawi, Justin Chen, Carol L. Karp
This case report describes the diagnosis and treatment of conjunctival papilloma in a patient aged 54 years who presented with a 3-month history of a painless lower left eyelid lesion.
本病例报告描述了结膜乳头状瘤的诊断和治疗,患者年龄54岁,表现为3个月的无痛左下眼睑病变史。
{"title":"Pedunculated Palpebral Conjunctival Papilloma","authors":"Wisam O. Najdawi, Justin Chen, Carol L. Karp","doi":"10.1001/jamaophthalmol.2025.5767","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5767","url":null,"abstract":"This case report describes the diagnosis and treatment of conjunctival papilloma in a patient aged 54 years who presented with a 3-month history of a painless lower left eyelid lesion.","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"8 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145972251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Language Accessibility at Select Academic Ophthalmology Centers Across US Metropolitan Areas 在美国大都市地区选择学术眼科中心的语言可访问性
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-15 DOI: 10.1001/jamaophthalmol.2025.5751
Sebastian Borges, Nicholas J. DeLuca, Victoria A. Pereira, Vitalia Borges, Kara M. Cavuoto
Importance Language concordance between patients and physicians may improve health outcomes; the extent to which academic ophthalmology centers meet the needs of limited English proficiency populations remains unclear. Objective To evaluate alignment between ophthalmologists language skills at US academic ophthalmology centers and linguistic needs of surrounding limited English proficiency populations. Design, Setting, and Participants This cross-sectional study included ophthalmologists affiliated with 32 ophthalmology programs across 28 metropolitan areas, identified from overlap of 2024-2025 <jats:italic toggle="yes">US News &amp;amp; World Report</jats:italic> “Best Hospitals for Ophthalmology” rankings and 2024 Blue Ridge Institute for Medical Research data on National Institutes of Health funding. Language and training data were collected from institutional websites and public sources. Exposures Ophthalmologist language offerings and local limited English proficiency (LEP) language composition derived from institutional websites and US Census Bureau American Community Survey data. Main Outcomes and Measures Language coverage (proportion of limited English proficiency languages represented by ophthalmologists), adjusted ratios (proportion of ophthalmologists speaking a language relative to the limited English proficiency population speaking it), and ophthalmologist availability (number of ophthalmologists per 10 000 limited English proficiency patients). Regional differences were tested using χ <jats:sup>2</jats:sup> and ANOVA tests. Results A mean of 330 (range, 314-367) ophthalmologists were evaluated per region. Across regions, total coverage was 45 of 82 ophthalmologists (54.9%) in the Northeast, 31 of 59 (52.5%) in the South, 29 of 72 (40.3%) in the West, and 24 of 74 (32.4%) in the Midwest. Coverage in the Midwest was lower than in the Northeast (difference, −0.22; 95% CI, −0.42 to −0.02; <jats:italic toggle="yes">P</jats:italic> = .03). Across 49 identified languages, only Spanish (mean adjusted ratio, 0.64 [95% CI, 0.28-1.00]) and Vietnamese (mean adjusted ratio, 0.86 [95% CI, 0.05-1.67]) were present in every region with consistent underrepresentation. Ophthalmologist availability was lowest for Spanish (mean adjusted ratio, 4.97 [95% CI, −4.49 to 14.43] per 10 000 limited English proficiency patients overall; &amp;lt;3.0 in 3 regions) and Chinese (mean adjusted ratio, 33.25 [95% CI, −33.26 to 99.76] per 10 000). Conclusions and Relevance In this cross-sectional study, academic ophthalmology centers demonstrated substantial gaps in language concordance, with Spanish-speaking patients disproportionately affected despite representing the largest limited English proficiency population nationally. These findings extend prior evidence of patient-level disparities by identifying potential workforce-level contributors to inequities in ophthalmic care and support targeted recruitment, training, and reporting strategies to expand Spa
患者和医生之间的语言一致性可以改善健康结果;学术眼科中心在多大程度上满足英语水平有限的人群的需求仍不清楚。目的评估美国眼科学术中心眼科医生的语言技能与周边有限英语熟练人群的语言需求之间的一致性。设计、环境和参与者本横断面研究包括28个大都市地区32个眼科项目的眼科医生,从2024-2025年US News的重叠部分确定。世界报告“最佳眼科医院”排名和2024年蓝岭医学研究所的数据由美国国立卫生研究院资助。语言和培训数据收集自机构网站和公共资源。来自机构网站和美国人口普查局美国社区调查数据的眼科医生语言产品和当地有限英语水平(LEP)语言组成。语言覆盖率(眼科医生所代表的有限英语熟练语言的比例)、调整比率(说一种语言的眼科医生相对于说这种语言的有限英语熟练人群的比例)和眼科医生可获得性(每1万名有限英语熟练患者的眼科医生人数)。采用χ 2和方差分析检验区域差异。结果每个地区平均有330名眼科医生(范围314-367)接受评估。从地区来看,东北地区82名眼科医生中有45名(54.9%),南部地区59名眼科医生中有31名(52.5%),西部地区72名眼科医生中有29名(40.3%),中西部地区74名眼科医生中有24名(32.4%)。中西部地区的覆盖率低于东北部(差异为- 0.22;95% CI, - 0.42至- 0.02;P = .03)。在49种确定的语言中,只有西班牙语(平均校正比,0.64 [95% CI, 0.28-1.00])和越南语(平均校正比,0.86 [95% CI, 0.05-1.67])在每个地区都存在一致的代表性不足。西班牙语(平均校正比为4.97 [95% CI, - 4.49至14.43]/ 1万名有限英语水平患者;3个地区为3.0)和汉语(平均校正比为33.25 [95% CI, - 33.26至99.76]/ 1万名)眼科医生的可用性最低。在这项横断面研究中,学术眼科中心显示了语言一致性的巨大差距,西班牙语患者受到的影响不成比例,尽管他们代表了全国最大的有限英语熟练人群。这些发现通过确定眼科护理不平等的潜在劳动力水平因素,扩展了先前患者水平差异的证据,并支持有针对性的招聘、培训和报告策略,以扩大西班牙语能力并解决特定地区的短缺问题。
{"title":"Language Accessibility at Select Academic Ophthalmology Centers Across US Metropolitan Areas","authors":"Sebastian Borges, Nicholas J. DeLuca, Victoria A. Pereira, Vitalia Borges, Kara M. Cavuoto","doi":"10.1001/jamaophthalmol.2025.5751","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5751","url":null,"abstract":"Importance Language concordance between patients and physicians may improve health outcomes; the extent to which academic ophthalmology centers meet the needs of limited English proficiency populations remains unclear. Objective To evaluate alignment between ophthalmologists language skills at US academic ophthalmology centers and linguistic needs of surrounding limited English proficiency populations. Design, Setting, and Participants This cross-sectional study included ophthalmologists affiliated with 32 ophthalmology programs across 28 metropolitan areas, identified from overlap of 2024-2025 &lt;jats:italic toggle=\"yes\"&gt;US News &amp;amp;amp; World Report&lt;/jats:italic&gt; “Best Hospitals for Ophthalmology” rankings and 2024 Blue Ridge Institute for Medical Research data on National Institutes of Health funding. Language and training data were collected from institutional websites and public sources. Exposures Ophthalmologist language offerings and local limited English proficiency (LEP) language composition derived from institutional websites and US Census Bureau American Community Survey data. Main Outcomes and Measures Language coverage (proportion of limited English proficiency languages represented by ophthalmologists), adjusted ratios (proportion of ophthalmologists speaking a language relative to the limited English proficiency population speaking it), and ophthalmologist availability (number of ophthalmologists per 10 000 limited English proficiency patients). Regional differences were tested using χ &lt;jats:sup&gt;2&lt;/jats:sup&gt; and ANOVA tests. Results A mean of 330 (range, 314-367) ophthalmologists were evaluated per region. Across regions, total coverage was 45 of 82 ophthalmologists (54.9%) in the Northeast, 31 of 59 (52.5%) in the South, 29 of 72 (40.3%) in the West, and 24 of 74 (32.4%) in the Midwest. Coverage in the Midwest was lower than in the Northeast (difference, −0.22; 95% CI, −0.42 to −0.02; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; = .03). Across 49 identified languages, only Spanish (mean adjusted ratio, 0.64 [95% CI, 0.28-1.00]) and Vietnamese (mean adjusted ratio, 0.86 [95% CI, 0.05-1.67]) were present in every region with consistent underrepresentation. Ophthalmologist availability was lowest for Spanish (mean adjusted ratio, 4.97 [95% CI, −4.49 to 14.43] per 10 000 limited English proficiency patients overall; &amp;amp;lt;3.0 in 3 regions) and Chinese (mean adjusted ratio, 33.25 [95% CI, −33.26 to 99.76] per 10 000). Conclusions and Relevance In this cross-sectional study, academic ophthalmology centers demonstrated substantial gaps in language concordance, with Spanish-speaking patients disproportionately affected despite representing the largest limited English proficiency population nationally. These findings extend prior evidence of patient-level disparities by identifying potential workforce-level contributors to inequities in ophthalmic care and support targeted recruitment, training, and reporting strategies to expand Spa","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"18 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145972252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome Metrics in Myopia Control Trials-Reply. 近视控制试验的结果指标-回复。
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-15 DOI: 10.1001/jamaophthalmol.2025.5771
Jianfeng Zhu,Hannan Xu,Xun Xu
{"title":"Outcome Metrics in Myopia Control Trials-Reply.","authors":"Jianfeng Zhu,Hannan Xu,Xun Xu","doi":"10.1001/jamaophthalmol.2025.5771","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5771","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"20 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145986454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric Orbital MALT Lymphoma Masquerading as a Pyogenic Granuloma 儿童眼眶MALT淋巴瘤伪装成化脓性肉芽肿
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-08 DOI: 10.1001/jamaophthalmol.2025.5067
Marie Callet, Marc Putterman, Augustin Lecler
This case report discusses a diagnosis of B-cell lymphoma mucosa-associated lymphoid tissue (MALT) in the conjunctiva of a young boy who presented with a painless, enlarging conjunctival mass.
本病例报告讨论的诊断b细胞淋巴瘤粘膜相关淋巴组织(MALT)在结膜的一个年轻的男孩谁提出了无痛,扩大结膜肿块。
{"title":"Pediatric Orbital MALT Lymphoma Masquerading as a Pyogenic Granuloma","authors":"Marie Callet, Marc Putterman, Augustin Lecler","doi":"10.1001/jamaophthalmol.2025.5067","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5067","url":null,"abstract":"This case report discusses a diagnosis of B-cell lymphoma mucosa-associated lymphoid tissue (MALT) in the conjunctiva of a young boy who presented with a painless, enlarging conjunctival mass.","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"391 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145919908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proteomic Profile in Retinopathy of Prematurity 早产儿视网膜病变的蛋白质组学分析
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-08 DOI: 10.1001/jamaophthalmol.2025.5594
Pia Lundgren, Hanna Danielsson, Mohit B. Panwar, María Bueno Álvez, Aldina Pivodic, Wen Zhong, Nele Brusselaers, Dirk Wackernagel, Ulrika Sjöbom, Karin Sävman, Ingrid Hansen Pupp, David Ley, Susanna Klevebro, Anders K. Nilsson, Zhongjie Fu, Lois E. H. Smith, Mathias Uhlén, Ann Hellström
Importance Identifying early proteomic profiles in infants who develop severe retinopathy of prematurity (ROP) may reveal targets for preventive interventions to reduce retinal vessel loss and the subsequent risk of severe ROP. Objective To assess early longitudinal profiles of blood protein levels in preterm infants with or without severe ROP and the effect of arachidonic acid (AA) and docosahexaenoic acid (DHA) supplementation. Design, Setting, and Participants This was an exploratory, post hoc analysis of serum proteome profiles in preterm infants in the double-masked Mega Donna Mega (MDM) randomized clinical trial using targeted Olink Proximity Extension Assay proteomics covering 538 analytes. The setting was 3 university hospitals in Sweden and included extremely preterm infants born before 28 weeks of gestational age (GA), from 2016 to 2019. Data were analyzed from January to March 2025. Exposures All infants received standard nutrition; additionally, half received enteral lipid supplementation with AA/DHA (100/50 mg/kg per day) from birth to term equivalent age. Main Outcomes and Measures Longitudinal protein profiles during the first month of life were examined using mixed models for repeated measures, adjusted for GA, study center, and AA/DHA supplementation, and tested for the interaction between severe ROP (stage ≥3 and/or treated) and postnatal age. Results A total of 177 extremely preterm infants (mean [SD] GA, 25.6 [1.4] weeks; 100 male [56.5%]) were included, of whom 50 (28.2%) developed severe ROP. Of 538 longitudinal analyzed proteins, 109 protein profiles in the first month of life associated with severe ROP, proteins related to immune response, apoptotic processes, blood coagulation, and lipid metabolism. The most pronounced association with severe ROP was a fast rise in fibroblast growth factor 21 (FGF-21; β = 0.68; 95% CI, 0.39-0.97; Q =.002) and tissue plasminogen activator (tPA; β = 0.21; 95% CI, 0.13-0.29; Q &amp;lt;.001) during the first postnatal days. The increase in serum FGF-21 level in the first week of life was associated with lower GA, lower birth weight, low enteral energy intake, and more days receiving mechanical ventilation. No association was observed between AA/DHA supplementation and the proteome. Conclusions and Relevance In this post hoc exploratory analysis of data from the MDM randomized clinical trial, a fast rise in FGF-21 levels, a metabolic stress-induced hormone, during the first postnatal days was strongly associated with the development of severe ROP in extremely preterm infants. These findings suggest that early interventions improving bioenergetic status may help prevent severe ROP. Trial Registration ClinicalTrials.gov Identifier: NCT03201588
确定严重早产儿视网膜病变(ROP)婴儿的早期蛋白质组学特征可能揭示预防干预的目标,以减少视网膜血管丢失和随后发生严重ROP的风险。目的探讨有或无严重ROP的早产儿早期血蛋白水平的纵向分布及补充花生四烯酸(AA)和二十二碳六烯酸(DHA)的影响。设计、环境和参与者:这是一项探索性的、事后分析早产儿血清蛋白质组谱的研究,该研究采用靶向Olink接近扩展测定蛋白质组学方法,在双屏蔽Mega Donna Mega (MDM)随机临床试验中对538种分析物进行分析。研究背景是瑞典的3所大学医院,包括2016年至2019年在28周胎龄(GA)之前出生的极早产儿。数据分析时间为2025年1月至3月。所有婴儿接受标准营养;此外,一半的小鼠从出生到足月等龄接受AA/DHA脂质补充(100/50 mg/kg /天)。使用重复测量的混合模型检查出生后第一个月的纵向蛋白质谱,调整GA、研究中心和AA/DHA补充,并测试严重ROP(≥3期和/或治疗)与出生后年龄之间的相互作用。结果共纳入177例极早产儿(平均[SD] GA 25.6[1.4]周,男性100例[56.5%]),其中50例(28.2%)发生严重ROP。在538个纵向分析的蛋白质中,109个蛋白质谱在生命的第一个月与严重ROP相关,蛋白质与免疫反应、凋亡过程、凝血和脂质代谢相关。与严重ROP最显著的关联是成纤维细胞生长因子21 (FGF-21; β = 0.68; 95% CI, 0.39-0.97; Q = 0.002)和组织纤溶酶原激活物(tPA; β = 0.21; 95% CI, 0.13-0.29; Q &lt;)的快速升高。001)在出生后的最初几天。出生后第一周血清FGF-21水平升高与较低的GA、较低的出生体重、较低的肠内能量摄入和接受机械通气的天数增加有关。没有观察到补充AA/DHA与蛋白质组之间的关联。在这项对MDM随机临床试验数据的事后探索性分析中,出生后最初几天FGF-21水平(一种代谢应激诱导激素)的快速上升与极早产儿严重ROP的发展密切相关。这些发现表明,早期干预改善生物能量状态可能有助于预防严重的ROP。临床试验注册:ClinicalTrials.gov标识符:NCT03201588
{"title":"Proteomic Profile in Retinopathy of Prematurity","authors":"Pia Lundgren, Hanna Danielsson, Mohit B. Panwar, María Bueno Álvez, Aldina Pivodic, Wen Zhong, Nele Brusselaers, Dirk Wackernagel, Ulrika Sjöbom, Karin Sävman, Ingrid Hansen Pupp, David Ley, Susanna Klevebro, Anders K. Nilsson, Zhongjie Fu, Lois E. H. Smith, Mathias Uhlén, Ann Hellström","doi":"10.1001/jamaophthalmol.2025.5594","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5594","url":null,"abstract":"Importance Identifying early proteomic profiles in infants who develop severe retinopathy of prematurity (ROP) may reveal targets for preventive interventions to reduce retinal vessel loss and the subsequent risk of severe ROP. Objective To assess early longitudinal profiles of blood protein levels in preterm infants with or without severe ROP and the effect of arachidonic acid (AA) and docosahexaenoic acid (DHA) supplementation. Design, Setting, and Participants This was an exploratory, post hoc analysis of serum proteome profiles in preterm infants in the double-masked Mega Donna Mega (MDM) randomized clinical trial using targeted Olink Proximity Extension Assay proteomics covering 538 analytes. The setting was 3 university hospitals in Sweden and included extremely preterm infants born before 28 weeks of gestational age (GA), from 2016 to 2019. Data were analyzed from January to March 2025. Exposures All infants received standard nutrition; additionally, half received enteral lipid supplementation with AA/DHA (100/50 mg/kg per day) from birth to term equivalent age. Main Outcomes and Measures Longitudinal protein profiles during the first month of life were examined using mixed models for repeated measures, adjusted for GA, study center, and AA/DHA supplementation, and tested for the interaction between severe ROP (stage ≥3 and/or treated) and postnatal age. Results A total of 177 extremely preterm infants (mean [SD] GA, 25.6 [1.4] weeks; 100 male [56.5%]) were included, of whom 50 (28.2%) developed severe ROP. Of 538 longitudinal analyzed proteins, 109 protein profiles in the first month of life associated with severe ROP, proteins related to immune response, apoptotic processes, blood coagulation, and lipid metabolism. The most pronounced association with severe ROP was a fast rise in fibroblast growth factor 21 (FGF-21; β = 0.68; 95% CI, 0.39-0.97; <jats:italic>Q</jats:italic> =.002) and tissue plasminogen activator (tPA; β = 0.21; 95% CI, 0.13-0.29; <jats:italic>Q</jats:italic> &amp;amp;lt;.001) during the first postnatal days. The increase in serum FGF-21 level in the first week of life was associated with lower GA, lower birth weight, low enteral energy intake, and more days receiving mechanical ventilation. No association was observed between AA/DHA supplementation and the proteome. Conclusions and Relevance In this post hoc exploratory analysis of data from the MDM randomized clinical trial, a fast rise in FGF-21 levels, a metabolic stress-induced hormone, during the first postnatal days was strongly associated with the development of severe ROP in extremely preterm infants. These findings suggest that early interventions improving bioenergetic status may help prevent severe ROP. Trial Registration ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" ext-link-type=\"uri\" xlink:href=\"https://www.clinicaltrials.gov/study/NCT03201588\">NCT03201588</jats:ext-link>","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"84 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145919905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unmasking a Masquerade of Ocular Dysgenesis 揭露眼部发育不良的伪装
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-08 DOI: 10.1001/jamaophthalmol.2025.5587
Nishtha Singh, Viney Gupta, Arnav Panigrahi
A 66-year-old man had nebulomacular corneal opacities, iris atrophy, and corectopia along with coarse facial skin, resorbed digits, anesthetic patches, and healed trophic skin ulcers. What would you do next?
66岁男性,角膜云雾斑混浊,虹膜萎缩,纠正性斜视,面部皮肤粗糙,手指吸收,麻醉斑块,营养性皮肤溃疡愈合。接下来你会做什么?
{"title":"Unmasking a Masquerade of Ocular Dysgenesis","authors":"Nishtha Singh, Viney Gupta, Arnav Panigrahi","doi":"10.1001/jamaophthalmol.2025.5587","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5587","url":null,"abstract":"A 66-year-old man had nebulomacular corneal opacities, iris atrophy, and corectopia along with coarse facial skin, resorbed digits, anesthetic patches, and healed trophic skin ulcers. What would you do next?","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"47 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145919907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ophthalmology Residency Match Rates by Applicant Demographics 申请人人口统计的眼科住院医师匹配率
IF 8.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-08 DOI: 10.1001/jamaophthalmol.2025.5581
Setu P. Mehta, Muhammad Ali, Ahmed Sabit, Laura K. Green, Jeff H. Pettey, R. Michael Siatkowski, Grace Sun, O’Rese J. Knight, Fasika A. Woreta
This cohort study assesses patterns in medical school students who matched with ophthalmology residency programs from 2021 to 2023, according to candidates’ sex, race, and ethnicity.
本队列研究根据候选人的性别、种族和民族,评估了2021年至2023年与眼科住院医师项目相匹配的医学院学生的模式。
{"title":"Ophthalmology Residency Match Rates by Applicant Demographics","authors":"Setu P. Mehta, Muhammad Ali, Ahmed Sabit, Laura K. Green, Jeff H. Pettey, R. Michael Siatkowski, Grace Sun, O’Rese J. Knight, Fasika A. Woreta","doi":"10.1001/jamaophthalmol.2025.5581","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2025.5581","url":null,"abstract":"This cohort study assesses patterns in medical school students who matched with ophthalmology residency programs from 2021 to 2023, according to candidates’ sex, race, and ethnicity.","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"44 1","pages":""},"PeriodicalIF":8.1,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145919906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Error in Table. 表中出现错误。
IF 9.2 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-01 DOI: 10.1001/jamaophthalmol.2025.6108
{"title":"Error in Table.","authors":"","doi":"10.1001/jamaophthalmol.2025.6108","DOIUrl":"10.1001/jamaophthalmol.2025.6108","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"144 1","pages":"114"},"PeriodicalIF":9.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12809356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145989152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Error in Open Access Status and in Results. 在开放存取状态和结果中出现错误。
IF 9.2 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-01 DOI: 10.1001/jamaophthalmol.2025.6124
{"title":"Error in Open Access Status and in Results.","authors":"","doi":"10.1001/jamaophthalmol.2025.6124","DOIUrl":"10.1001/jamaophthalmol.2025.6124","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"144 1","pages":"114"},"PeriodicalIF":9.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12809361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145989147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of Optic Disc Edema Progression in Spaceflight. 太空飞行视盘水肿进展的预测。
IF 9.2 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2026-01-01 DOI: 10.1001/jamaophthalmol.2025.4652
Anokhi S Kholwadwala, Andrew G Lee
{"title":"Prediction of Optic Disc Edema Progression in Spaceflight.","authors":"Anokhi S Kholwadwala, Andrew G Lee","doi":"10.1001/jamaophthalmol.2025.4652","DOIUrl":"10.1001/jamaophthalmol.2025.4652","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":" ","pages":"40-41"},"PeriodicalIF":9.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145563656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JAMA ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1